Alkermes (ALKS) Common Equity (2010 - 2026)

Alkermes (ALKS) has reported Common Equity for 17 consecutive years, with $1.8 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Common Equity rose 11.32% year-over-year to $1.8 billion in Q2 2026; TTM through Jun 2026 was $1.8 billion, a 11.32% increase from a year earlier, with the FY2025 full-year figure at $1.8 billion, up 24.19% from the prior year.
• Common Equity was $1.8 billion for Q2 2026 at Alkermes, up from $1.8 billion in the prior quarter.
• Over five years, Common Equity peaked at $1.8 billion in Q4 2025 and troughed at $1.0 billion in Q1 2023.
• A 5-year average of $1.4 billion and a median of $1.3 billion in 2024 frame the typical range for Common Equity.
• Across the five-year window, Common Equity fell 6.49% in 2023 and surged 34.16% in 2025, its largest moves.
• Over 5 years, Common Equity stood at $1.0 billion in 2022, then gained by 15.23% to $1.2 billion in 2023, then rose by 21.81% to $1.5 billion in 2024, then climbed by 24.19% to $1.8 billion in 2025, then fell by 0.59% to $1.8 billion in 2026.
• The last three Common Equity figures came in at $1.8 billion (Q2 2026), $1.8 billion (Q1 2026), and $1.8 billion (Q4 2025), per Business Quant data.